Company Stellar Biotechnologies Inc Nasdaq
Equities
CA85855A3029
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 07-06-11 |
Michael Brooks
PSD | President | 46 | 15-08-31 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 23-07-14 |
Blair Gordon
CTO | Chief Tech/Sci/R&D Officer | - | 16-08-31 |
Gary Koppenjan
IRC | Investor Relations Contact | - | 18-12-31 |
Raj Puri
PRN | Corporate Officer/Principal | - | 21-06-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 19-06-06 |
Frank Oakes
BRD | Director/Board Member | 73 | 10-04-08 |
Patrick Marshall
BRD | Director/Board Member | 53 | 23-05-22 |
Joan Chypyha
BRD | Director/Board Member | 57 | 23-05-22 |
Charles Olson
BRD | Director/Board Member | 66 | 23-05-22 |
Pardeep Nijhawan
FOU | Founder | 53 | 07-06-11 |
Carlo Sistilli
CHM | Chairman | 67 | 19-06-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,215,968 | 2,120,255 ( 65.93 %) | 0 | 65.93 % |
Company contact information
![address Stellar Biotechnologies Inc](https://cdn.zonebourse.com/static/address/43428073.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
+4.60% | 22.94B | |
-9.86% | 17.02B | |
-16.26% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B | |
+106.26% | 10.31B |